Sri Lanka hill country treatment setting - residential rehab clinic in Asia

Key takeaways

  • The liver can process approximately one standard drink per hour; excess alcohol and the toxic compound acetaldehyde accumulate dangerously in the bloodstream.
  • Alcohol-related liver disease progresses through three reversible or manageable stages: fatty liver, hepatitis, and cirrhosis - with early intervention offering the greatest impact.
  • Approximately 10 to 20 percent of people with alcohol use disorder develop cirrhosis, with progression possible in as little as ten years of heavy drinking.
  • Fatty liver is completely reversible within weeks of stopping drinking, but advanced cirrhosis cannot regenerate fibrosed tissue though abstinence prevents further progression.
  • Standard liver function tests can show normal results despite significant fibrosis, making Fibroscan (transient elastography) a more reliable non-invasive measure of liver damage.

The liver's role in processing alcohol

The liver is the primary organ responsible for metabolising alcohol. When alcohol is consumed, it travels through the gastrointestinal tract to the liver, where enzymes - primarily alcohol dehydrogenase - convert it first to acetaldehyde (a highly toxic compound) and then to acetate, which is relatively harmless. The liver can process roughly one standard drink per hour. Anything beyond this rate means that excess alcohol, and the intermediate compound acetaldehyde, accumulate in the bloodstream.

Acetaldehyde is important to understand because it is significantly more toxic than alcohol itself. It reacts with proteins and DNA, disrupts mitochondrial function, and triggers inflammatory responses in liver cells. Much of the long-term damage that alcohol causes to the liver is mediated by acetaldehyde rather than by alcohol directly. For a comprehensive overview of how alcohol affects health, the NIAAA's guide to alcohol's effects on health provides evidence-based information.

Alcohol-related liver disease (ALD) progresses through identifiable stages, and the early stages are reversible with abstinence. This is important: liver disease is not a fixed endpoint. For most people, significant recovery is possible if alcohol use is stopped early enough.

Is this something you're dealing with?

Free confidential advice - no pressure, no obligation.

Talk to us

Alcoholic fatty liver (steatosis)

Fatty liver develops in almost everyone who drinks heavily, often within as few as a few days of sustained heavy drinking. Fat accumulates in liver cells because the metabolic process of breaking down alcohol diverts the liver's resources away from normal fat metabolism. At this stage, the liver is enlarged but functioning. There are typically no symptoms. Most people are unaware they have it.

Fatty liver is completely reversible. In the majority of people, cessation of heavy drinking returns the liver to normal within several weeks. This is the stage at which intervention has the greatest impact.

Alcoholic hepatitis

In people who continue to drink heavily, fatty liver can progress to alcoholic hepatitis - inflammation of the liver caused by sustained exposure to alcohol and its metabolites. Alcoholic hepatitis ranges enormously in severity, from mild and asymptomatic to severe and life-threatening.

Symptoms of alcoholic hepatitis include jaundice (yellowing of the skin and whites of the eyes), abdominal pain, nausea, fever, and fatigue. In severe cases - classified by the Maddrey Discriminant Function, a scoring system used by clinicians to assess severity - mortality without treatment can be over 50%. Corticosteroids are used in severe cases, but the primary intervention is cessation of alcohol.

Alcoholic hepatitis can develop rapidly, even in people who have been drinking for relatively short periods. It does not require decades of heavy use.

Cirrhosis

Cirrhosis is the end-stage of alcohol-related liver disease. Sustained inflammation causes normal liver cells to be replaced by scar tissue (fibrosis), progressively impairing the liver's ability to function. Unlike fatty liver and some forms of alcoholic hepatitis, cirrhosis is not reversible. Once fibrosis has replaced a significant proportion of liver tissue, that tissue cannot regenerate.

Cirrhosis causes a range of serious complications: portal hypertension (increased blood pressure in the veins supplying the liver), ascites (fluid accumulation in the abdomen), variceal bleeding (rupture of enlarged blood vessels in the oesophagus), hepatic encephalopathy (confusion and altered consciousness caused by the liver's inability to clear toxins), and a significantly elevated risk of liver cancer (hepatocellular carcinoma).

Not everyone who drinks heavily will develop cirrhosis. Genetic factors play a significant role in individual susceptibility. But approximately 10 to 20 percent of people with alcohol use disorder develop cirrhosis, and the timeline can be as short as ten years of heavy drinking in susceptible individuals.

The silent progression: One of the most important things to understand about alcohol-related liver disease is that it is largely asymptomatic until it reaches an advanced stage. The absence of symptoms does not indicate the absence of damage. Many people with significant fibrosis or even early cirrhosis feel entirely well. By the time symptoms appear, the disease is often at a stage where options are more limited.

What blood tests show - and what they miss

Liver function tests (LFTs) are a standard part of routine health screening and are commonly ordered by GPs when alcohol use is a concern. They measure markers including ALT, AST, GGT, alkaline phosphatase, and bilirubin. Elevated results suggest liver inflammation or damage.

However, liver function tests have significant limitations. GGT is elevated in most people who drink heavily, but its elevation is not specific to liver disease - it is a marker of alcohol consumption rather than liver damage per se. Conversely, LFTs can be normal even in the presence of significant fibrosis, because scar tissue replacement of liver cells does not necessarily produce elevated enzymes. This is why understanding high-functioning patterns of alcohol use and their hidden damage is crucial.

Fibroscan (transient elastography) is a non-invasive imaging test that measures liver stiffness and provides a much more reliable picture of fibrosis. It is increasingly available in specialist hepatology clinics and should be requested when alcohol use disorder is suspected, rather than relying on LFTs alone. A liver biopsy provides the most definitive information but is invasive and not required in most cases.

Recovery of liver function after stopping drinking

The liver's capacity for recovery is remarkable, and it is important that this is understood. For people in the early to middle stages of alcohol-related liver disease, stopping drinking produces substantial improvement in liver function and, for many, reversal of the underlying damage.

In people with fatty liver, complete recovery is typical within weeks of abstinence. In people with alcoholic hepatitis, abstinence significantly improves outcomes even in severe cases. In people with established cirrhosis, abstinence will not reverse the fibrosis but will prevent further progression, reduce the risk of complications, and substantially improve prognosis. The difference in five-year survival between people with cirrhosis who maintain abstinence and those who continue to drink is significant.

This is not a theoretical distinction. It is the clinical reality that motivates the medical community's emphasis on early intervention: the window during which meaningful recovery of liver function is possible is wide, but it is not unlimited.

Alcohol and the gut-liver axis

Research over the past decade has significantly advanced understanding of the mechanism by which alcohol damages the liver, particularly through its effects on the gut microbiome. Heavy alcohol use disrupts the intestinal barrier, increasing permeability and allowing bacteria and their products (particularly lipopolysaccharide, or LPS) to translocate from the gut into the portal circulation and reach the liver. This triggers a chronic inflammatory response that drives fibrosis.

This pathway helps explain why liver disease progresses even in people who are not drinking every day, and it suggests emerging therapeutic targets beyond simple abstinence. It also reinforces the importance of nutrition - gut health, adequacy of protein intake, and vitamin status all influence the trajectory of liver disease.

When to seek help

If you are drinking daily, or drinking at levels that you suspect may be harmful, the time to seek assessment is now - not after symptoms appear. A GP can order initial blood tests and a Fibroscan referral. A specialist hepatologist should be involved where any liver disease is suspected.

Addressing the drinking is a separate but parallel conversation. Alcohol dependence - physical dependence that makes stopping difficult or dangerous without medical supervision - requires structured support, not willpower alone. Medically supervised withdrawal followed by residential or intensive outpatient treatment offers the highest chance of sustained abstinence, which remains the single most powerful intervention for alcohol-related liver disease at any stage.

Ready to talk?

Free confidential advice about alcohol treatment in Sri Lanka. No obligation - just honest information about your options.

Get free advice
Christopher Murray - cognitive hypnotherapist and co-founder of Sansun Group

About the author

Christopher Murray

Dip.C.Hyp · HPD · NLP · MNCH

Christopher Murray is a cognitive hypnotherapist, NLP practitioner, and author of The Confidence Reset. Co-founder of the Sansun Group, he works with high-functioning individuals internationally and advises families and clients navigating addiction treatment and rehabilitation across Asia.

Sources

  1. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol's Effects on Health. US Department of Health and Human Services.
  2. World Health Organization. Alcohol - Key Facts. WHO.
  3. National Institute on Drug Abuse. The Science of Drug Use and Addiction. US Department of Health and Human Services.